Artificial Intelligence and FDA Oversight: Where We Are Now

Artificial intelligence (AI) is transforming healthcare, impacting everything from medical devices and clinical decision support (CDS) to drug application submissions. This half-day virtual conference will explore FDA’s evolving approach to regulating AI in this broad context. Experts will discuss AI-enabled medical devices; CDS software; the use of AI in pharmaceutical research and development (R&D); and data privacy issues, including state, federal, and international regulations on clinical data use. Panelists also will provide practical data management tips.